Brain+ AS (OCSE:BRAINP) Other Financing: kr-5.36 Mil (TTM As of Jun. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Brain+ AS Other Financing?

Brain+ AS OCSE:BRAINP Other Financing is kr-5.36 Mil as of Jun. 2025. The stock has 4 warning signs investors should review.

Brain+ AS's Other Financing for the six months ended in Jun. 2025 was kr-4.35 Mil.

Brain+ AS's Other Financing for the trailing twelve months (TTM) ended in Jun. 2025 was kr-5.36 Mil.

Brain+ AS Other Financing Historical Data

* Premium members only.

The historical data trend for Brain+ AS's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Brain+ AS Other Financing Chart

Brain+ AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Other Financing
Get a 7-Day Free Trial 0.00 -3.09 -0.94 -3.38 -2.35

Brain+ AS Semi-Annual Data
Dec19 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -3.15 -0.23 -1.34 -1.01 -4.35

Brain+ AS Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Jun. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr-5.36 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of kr-5.36 Mil mean?
Brain+ AS (OCSE:BRAINP) has a Other Financing of kr-5.36 Mil as of Jun. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Brain+ AS and its competitors.
Is Brain+ AS's Other Financing too high?
Brain+ AS's current Other Financing is kr-5.36 Mil.
How does Brain+ AS's Other Financing compare to VEEV and BTSG?
Brain+ AS's Other Financing of kr-5.36 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Brain+ AS and its competitors. Brain+ AS's current Other Financing is kr-5.36 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Brain+ AS stock overvalued right now?
Brain+ AS (OCSE:BRAINP) has a current Other Financing of kr-5.36 Mil. The current Other Financing is kr-5.36 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Brain+ AS (OCSE:BRAINP), the current Other Financing is kr-5.36 Mil as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Brain+ AS Business Description

Address Svanevej 22, 2nd floor, Copenhagen, DNK, 2400
Brain+ AS is a digital therapeutics company. It is focused on developing and commercializing solutions for dementia care and with a primary focus on Cognitive Stimulation Therapy (CST). The company has developed a set of Digital Medicine technologies. Its product pipeline includes CST Therapist Companion, and CST Home Companion; CST Home Care; CST for Mild Cognitive Impairment (MCI). The company is developing Ayla, a scalable dementia care platform that provides software-based therapy and care solutions designed to support individuals with dementia.